Minireviews
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Sep 26, 2017; 9(9): 737-741
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.737
Brugada type 1 electrocardiogram: Should we treat the electrocardiogram or the patient?
Pietro Delise, Giuseppe Allocca, Nadir Sitta
Pietro Delise, Division of Cardiology, Clinica Pederzoli, Peschiera SG, 37019 Verona, Italy
Giuseppe Allocca, Nadir Sitta, Division of Cardiology, Hospital of Conegliano, 31015 Treviso, Italy
Author contributions: Delise P was the guarantor of the study, prepared the figure and tables; Allocca G and Sitta N participated in the acquisition and interpretation of the data.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Pietro Delise, MD, Division of Cardiology, Clinica Pederzoli, Peschiera SG, Via Felisati 66, 37019 Verona, Italy. pietro.delise@libero.it
Telephone: +39-41-975205
Received: January 12, 2017
Peer-review started: January 16, 2017
First decision: April 27, 2017
Revised: July 6, 2017
Accepted: July 21, 2017
Article in press: July 24, 2017
Published online: September 26, 2017
Processing time: 255 Days and 9.7 Hours
Abstract

Patients with a Brugada type 1 electrocardiogram (ECG) pattern may suffer sudden cardiac death (SCD). Recognized risk factors are spontaneous type 1 ECG and syncope of presumed arrhythmic origin. Familial sudden cardiac death (f-SCD) is not a recognized independent risk factor. Finally, positive electrophysiologic study (+EPS) has a controversial prognostic value. Current ESC guidelines recommend implantable cardioverter defibrillator (ICD) implantation in patients with a Brugada type 1 ECG pattern if they have suffered a previous resuscitated cardiac arrest (class I recommendation) or if they have syncope of presumed cardiac origin (class IIa recommendation). In clinical practice, however, many other patients undergo ICD implantation despite the suggestions of the guidelines. In a 2014 cumulative analysis of the largest available studies (including over 2000 patients), we found that 1/3 of patients received an ICD in primary prevention. Interestingly, 55% of these latter were asymptomatic, while 80% had a + EPS. This means that over 30% of subjects with a Brugada type 1 ECG pattern were considered at high risk of SCD mainly on the basis of EPS, to which a class IIb indication for ICD is assigned by the current ESC guidelines. Follow-up data confirm that in clinical practice single, and often frail, risk factors overestimate the real risk in subjects with the Brugada type 1 ECG pattern. We can argue that, in clinical practice, many cardiology centers adopt an aggressive treatment in subjects with a Brugada type 1 ECG pattern who are not at high risk. As a result, many healthy persons may be treated in order to save a few patients with a true Brugada Syndrome. Better risk stratification is needed. A multi-parametric approach that considers the contemporary presence of multiple risk factors is a promising one.

Keywords: Brugada syndrome; Brugada type 1 electrocardiogram; Sudden cardiac death

Core tip: On the basis of frail risk factors, many cardiology centers adopt an aggressive treatment in subjects with a Brugada type 1 electrocardiogram pattern who are not at high risk. As a result, many healthy persons may be treated in order to save a few patients with a true Brugada Syndrome. Better risk stratification is needed, for example the adoption of a multiparametric approach.